AMGEN Inc (NASDAQ: AMGN) kicked off on Tuesday, up 4.57% from the previous trading day, before settling in for the closing price of $323.66. Over the past 52 weeks, AMGN has traded in a range of $253.30-$335.88.
A company in the Healthcare sector has dropped its sales by -10.10% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 7.11%. With a float of $537.37 million, this company’s outstanding shares have now reached $538.50 million.
AMGEN Inc (AMGN) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – General Industry. The insider ownership of AMGEN Inc is 0.21%, while institutional ownership is 81.26%. The most recent insider transaction that took place on Aug 20 ’25, was worth 376,280. In this transaction SVP & CCO of this company sold 1,267 shares at a rate of $296.99, taking the stock ownership to the 7,209 shares. Before that another transaction happened on Aug 20 ’25, when Company’s Officer proposed sale 1,267 for $294.32, making the entire transaction worth $372,909.
AMGEN Inc (AMGN) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported 5.31 earnings per share (EPS), higher than consensus estimate (set at 5.08) by 0.23. Wall Street market experts anticipate that the next fiscal year will bring earnings of 5.05 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 7.11% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 4.34% during the next five years compared to -10.10% drop over the previous five years of trading.
AMGEN Inc (NASDAQ: AMGN) Trading Performance Indicators
Take a look at AMGEN Inc’s (AMGN) current performance indicators. Last quarter, stock had a quick ratio of 0.99. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.08. Likewise, its price to free cash flow for the trailing twelve months is 15.79.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 12.94, a number that is poised to hit 4.82 in the next quarter and is forecasted to reach 21.73 in one year’s time.
Technical Analysis of AMGEN Inc (AMGN)
Let’s dig in a bit further. During the last 5-days, its volume was 3.43 million. That was better than the volume of 2.74 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 95.08%.
During the past 100 days, AMGEN Inc’s (AMGN) raw stochastic average was set at 99.86%, which indicates a significant increase from 99.80% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 7.86 in the past 14 days, which was higher than the 6.64 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $291.69, while its 200-day Moving Average is $292.73. However, in the short run, AMGEN Inc’s stock first resistance to watch stands at $343.53. Second resistance stands at $348.60. The third major resistance level sits at $358.66. If the price goes on to break the first support level at $328.40, it is likely to go to the next support level at $318.34. The third support level lies at $313.27 if the price breaches the second support level.
AMGEN Inc (NASDAQ: AMGN) Key Stats
The company with the Market Capitalisation of 182.25 billion has total of 538,481K Shares Outstanding. Its annual sales at the moment are 33,424 M in contrast with the sum of 4,090 M annual income. Company’s last quarter sales were recorded 9,557 M and last quarter income was 3,216 M.
